One of GALVmed’s key technology partners has been included in this year’s edition of a prestigious UK government publication.
Cambridge-based biopharmaceutical company Arecor is profiled in the Technology edition of the Parliamentary Review as an example of ‘an outstanding organisation and growth company’.
Established by former minister Rt Hon David Curry shortly after the 2010 UK general election, the Parliamentary Review’s September release has become a key fixture in the UK political calendar, demonstrating how sector leaders have responded to challenges in the political and economic environment.
The publication showcases best practice and acts as a learning tool to the public and private sector and is aimed particularly at leading policymakers and executives within the technology sector.
Dr Sarah Howell, Chief Executive of Arecor, said: “We at Arecor are thrilled to have been chosen to feature in this year’s Review alongside such an august and select group of companies.
GALVmed’s Chief Scientific Officer Jeremy Salt commented: “At GALVmed we would all like to add our congratulations to Arecor on this recognition that they have received.
“Over the last five years Arecor has been a key strategic partner for GALVmed in our pursuit of high quality technology developments to aid the smallholder farmer in sub-Saharan Africa and S Asia.
“We are grateful to Arecor staff for their dedication to our various joint projects to improve vaccines for East Coast Fever, Peste de Petits Ruminantes and Newcastle Disease.
“We look forward to future collaborations and more successes for Arecor.”
An e-copy of the Technology edition of the 2017 Parliamentary Review can be viewed at https://www.theparliamentaryreview.co.uk/editions/technology/technology.